Rs 5,000 Crore Initiative Set to Propel India's Pharma and MedTech Sector into Rapid Growth

The scheme intends to increase the pharmaceutical industry's worth from its present level of USD 50 billion to USD 130 billion by 2030. According to reputable government sources, the health ministry will soon unveil a comprehensive five-year plan...

WuXi Biologics and Boostimmune Sign an Agreement for Exclusive Research and Discovery Services

WuXi Biologics (WuXi Bio), a leading global CRDMO, and Boostimmune, a biotech company dedicated to developing next-generation anti-cancer therapies modulating the tumour immune microenvironment and ADCs to novel targets, announced the signing...

77 Years of Independence Day: An Outstanding Achievement in Cultural Resilience and Health Awareness

Today, India commemorates a truly special occasion as it marks the 77th anniversary of Thindependence Day. This unique celebration has evolved over the years from being a mere health-conscious event to a symbol of cultural resilience, unity,...

Lupin gets US FDA nod for Doxycycline Hyclate Delayed-Release Tablets USP

Lupin Limited announced that it has received FDA approval for its Abbreviated New Drug Application for doxycycline hyclate delayed-release tablets USP, 50 mg, 60 mg, 75 mg, 80 mg, 100 mg, 120 mg, 150 mg, and 200 mg, to market a generic equivalent...

Exor Acquires a 15% Stake in Philips for Approximately $2.8 Billion

Philips announced earlier this week that Dutch investment firm Exor NV has acquired a 15% stake in the company for approximately 2.6 billion euros ($2.84 billion)...

AIIMS Delhi inks MoU with GGSIP University to Revolutionise Patient Care

AIIMS Delhi and Guru Gobind Singh Indraprastha University (GGSIPU) have announced a strategic collaboration aimed at revolutionizing patient care through the implementation of a patient grievance redressal system.

Parliamentary Panel asks Govt to Execute Mental Healthcare Act and Monitor Insurance Delivery

A Parliamentary Panel that investigated the country's mental healthcare and management policies found that, despite the fact that the Mental Healthcare Act (MHCA), 2017 was introduced five years ago, there is still much work...

How Gene Editing Technologies are Transforming Pharma

Gene editing technologies, particularly CRISPR-Cas9, are redefining the pharmaceutical industry by facilitating scientists to manipulate the genetic code with unprecedented precision

Monoclonal Antibodies: Revolutionizing Drug Discovery and Development

Ground-breaking discoveries in the field of modern medicine frequently result from creative strategies for medication development and research.

India Should Work with Canadian pharmaceutical Regulatory Agencies to Encourage Investment in the country, say Experts

According to trade specialists, the Indian government wants Canadian regulatory agencies to recognise and commercialise pharmaceutical items in order to incentivize investment opportunities...

© 2025 India Pharma Outlook. All Rights Reserved.